Inclisiran Durably Lowers Ldl-C And Pcsk9 Expression In Subjects With Homozygous Familial Hypercholesterolaemia: The Orion-2 Pilot Study. (August 2019) - Raal, F.; Lepor, N.; Kallend, D.; Stoekenbroek, R.; Wijngaard, P.; Hovingh, G.K.